Newsletter | February 4, 2026

02.04.26 -- Why 'Be Your Authentic Self' Is Actually Bad Advice

FEATURED ARTICLE

Why 'Be Your Authentic Self' Is Actually Bad Advice

‘Be your authentic self’ sounds empowering, but it can mislead ambitious professionals. Discover a more strategic approach to authenticity that balances values, context, and impact — so you can build trust, protect credibility, and navigate complex organizations effectively.

INDUSTRY INSIGHTS

5 Questions That Put Sponsors Back in Control of Bioanalysis Projects

Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

How T3P Can Enable Greener, Cost-Effective Peptide Synthesis

Read how our collaboration with the Peptide Science Laboratory Institution is transforming peptide synthesis with green chemistry, paving the way for more sustainable and cost-effective pharmaceutical production.

A Guide To Streamlining Study Start-Up In Australia

Learn the benefits of Australia as a premier destination for multinational sponsors looking to expedite drug development, refine trial design, and establish long-term research partnerships.

Insights For Innovation: AMCP Nexus 2025 Educational Videos

Explore our curated collection of expert-led educational sessions from AMCP Nexus 2025, covering key topics including updates on AMCP Format 5.0, strategic payer engagement tactics, AI-driven innovations, and more.

Why Early Medical Assessment Matters In Clinical Trials

Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Uncover how starting early boosts compliance, speeds timelines, and protects participants and results.

How Cara Therapeutics Increased Compliance And Reduced Study Team Burden

Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.